This is a Phase 3, international, randomised, investigator-blind, multicentre, vehicle and
comparator controlled, parallel-group, 3-arm trial for subjects with mild-to-moderate psoriasis
vulgaris. Subjects will apply trial medication to affected non-scalp areas of the body (trunk and/or limbs) topically once daily for 8 weeks.The maximum trial duration for each subject will be approximately 14 weeks and includes a screening period of up to 4 weeks (if washout of prohibited medications is required), an 8-week treatment period, and a follow-up period of 2 weeks.
Do you Qualify?
These questions require a yes answer to qualify.
Are you at least 18 years of age?
Have you been clinically diagnosed for at least 6 months?
Does the effected area cover between 2% and 30% of your body?
These questions require a no answer to qualify.
Are you currently pregnant, plan to become pregnant or breastfeeding?
Have you taken any biologic therapy for psoriasis treatment?
Currently suffering from any major illnesses that may require extended hospitalization?
Do you suffer from any other inflammatory skin diseases?
If you think you may be eligible for this trial, please give us a call to schedule an appointment or click button below to email a request.